The Respiratory Laboratory at the Guam Memorial Hospital Authority has earned recertification of its respiratory services ...
Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. (EDI) to offer the ECL100, a fully automated chemiluminescent immunoassay analyzer, and 50+ CLIA kits to laboratories across North ...
Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...
It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...
OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, today announced that it has received a laboratory permit from the New York State ...
News Medical on MSN
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer ...
Medical Device Network on MSN
Biodesix and Bio-Rad expand collaboration for IVD assays development
Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...
Stockhead on MSN
ASX Quarterly Health Wrap: Lumos lands US$317m deal as ReNerve and Vitrafy hit key milestones
In partnership with the U.S. Army Institute of Surgical Research (USAISR), Vitrafy began the second phase of its platelet ...
Investing.com -- Biodesix (NYSE:BDSX) stock rose 10% Wednesday after the diagnostics solutions company announced an expanded partnership agreement with Bio-Rad Laboratories to develop high complexity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback